Motilal Oswal BSE Healthcare ETF share price
AMFI: 150445ISIN: INF247L01BB1Motilal Oswal Mutual FundETFs
Close ₹50.29up ₹0.61 (1.23%)
Close on 28 Oct 2026, traded as MOHEALTH. Day's range ₹49.44 to ₹50.43, 44,015 units traded.
52-week range of traded prices to 28 Oct 2026
₹40.79Low, 2 Apr 2026₹53.89High, 21 Sep 2026
- NAVNet asset value (NAV). What one unit of the fund is worth: everything the fund owns, less what it owes, divided by the units held by investors, worked out once a day after the market closes. Net asset value (NAV) in the glossary
- ₹49.636827 Oct 2026
- Premium to NAVPremium or discount. How far the ETF's closing price on the exchange was above or below its NAV the same day: the close divided by that day's NAV, less one. Above the NAV is a premium, below it a discount. Premium or discount in the glossary
- +0.09%27 Oct 2026
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month. Assets under management in the glossary
- ₹44 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it. Total expense ratio: how it is worked out
- 0.36%23 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought. Exit load in the glossary
- None
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot pull the fund's P/E down. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted. P/E in the glossary
- 40.230 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. Riskometer in the glossary
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures. Holdings in the glossary
- 13830 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer. Launch date in the glossary
- 29 Jul 2022
Motilal Oswal BSE Healthcare ETF returns
Over each window to 27 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). Trailing return: how it is worked out | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. Benchmark in the glossary |
|---|---|---|
| 1 week | +2.39% | – |
| 1 month | −5.23% | – |
| 3 months | −2.54% | – |
| 6 months | +9.74% | – |
| 1 year | +9.37% | +16.77%to 30 Sep 2026 |
| 3 years | +21.79% | +21.25%to 30 Sep 2026 |
| 5 years | Needs 5 years | – |
₹10,000 put in on 4 Aug 2022 is ₹21,343 at the NAV of 27 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load. Growth of ₹10,000 in the glossaryOver a year and longer, a return is the yearly rate. Benchmark: BSE Healthcare TRI, over the same days as the fund, or to the month end its cell names.
At the month end, 30 Sep 2026
| Over | Fund | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. Benchmark return in the glossary |
|---|---|---|
| 1 year | +16.55% | +16.77% |
| 3 years | +20.94% | +21.25% |
| Since launch | +21.02% | +21.35% |
Benchmark: BSE Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- FundCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Loss
Highest year to Dec 2024, +43.8%; lowest year to Dec 2025, −2.9%
Motilal Oswal BSE Healthcare ETF SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 27 Oct 2026SIP calculator
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. Amount invested in the glossary | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. Value today in the glossary | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. SIP return (XIRR) in the glossary | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. SIP return after stamp duty in the glossary | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. Stamp duty paid in the glossary |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,28,344₹1,28,338 after stamp duty | +13.44% | +13.43% | ₹6 | |
| 3 years36 instalments | ₹3,60,000 | ₹4,34,482₹4,34,460 after stamp duty | +12.70% | +12.69% | ₹18 | |
| Since Aug 202250 instalments | ₹5,00,000 | ₹7,21,838₹7,21,802 after stamp duty | +17.89% | +17.89% | ₹25 |
5 years: Launched 29 Jul 2022, needs 5 years of history.
A SIP that rises every year: Step-up SIP calculator
Rolling returns
Per cent a year, every window from 4 Aug 2022 to 27 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The lowest yearly return of any window of this length in the fund's history, one window starting on each day it priced. Lowest rolling return in the glossaryAverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history. Average rolling return in the glossaryHighestHighest rolling return. The highest yearly return of any window of this length in the fund's history. Highest rolling return in the glossaryEnded higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started. Windows that ended higher in the glossary
1 year798 windows−3.9%+25.3%+64.2%94.5%
3 years304 windows+19.4%+24.1%+28.4%100.0%
5 yearsLaunched 29 Jul 2022, needs 6 years of history
Every 3-year window ended higher than it started.
Tracking error
Against BSE Healthcare Total Return Index, as on 30 Sep 2026.
Against its index, by window
| Measure | This fund |
|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. Tracking error in the glossary | 0.08% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. Tracking difference in the glossary | −0.22 pts |
| Difference, 3 years | −0.31 pts |
| Difference since launch | −0.32 pts |
Difference: the fund's return less the index's, in percentage points.
Premium or discount to NAV, each session, MOHEALTH
- Premium
Highest +0.98%, 22 Oct 2026.Lowest −0.48%, 26 Oct 2026.
Motilal Oswal BSE Healthcare ETF expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies. Expense ratio, 30-day average in the glossary
- 0.36%Over the last 30 days filed
Total expense ratio, month by month
Expense ratio highest 0.43%, Jul 2026.Expense ratio lowest 0.20%, Dec 2022.
What the expense ratio is made of
| Part | A year |
|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. Base expense ratio in the glossary | 0.21% |
| Brokerage | 0.02% |
| Transaction costs | None |
| Statutory levies | 0.13% |
Per cent of assets a year, filed for 23 Oct 2026. The parts add up to that day's total.
Motilal Oswal BSE Healthcare ETF AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹44 CrQuarter to Sep 2026
Average assets by quarter
The latest quarter is the largest since the quarter to Jun 2022.
Assets at each month end
Highest ₹45 Cr, Aug 2026.Lowest ₹8 Cr, Aug 2023.
Motilal Oswal BSE Healthcare ETF portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. Large, mid and small cap in the glossary | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. Weight in the fund in the glossary | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. Held since in the glossary | |||
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Large cap13th | 12.33% | 5.47 | 30,082 | Jul 2022or earlier |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Large cap50th | 7.42% | 3.30 | 3,550 | Jul 2022or earlier |
| Apollo Hospitals EnterpriseHealthcare Services | Large cap97th | 5.21% | 2.31 | 2,844 | Jul 2022or earlier |
| Laurus LabsPharmaceuticals & Biotechnology | Mid cap171st | 4.84% | 2.15 | 10,839 | Jul 2022or earlier |
| CiplaPharmaceuticals & Biotechnology | Large cap99th | 4.79% | 2.13 | 15,756 | Jul 2022or earlier |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | Mid cap104th | 4.73% | 2.10 | 16,976 | Jul 2022or earlier |
| Max Healthcare InstituteHealthcare Services | Mid cap111th | 4.32% | 1.92 | 20,609 | Jul 2022or earlier |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Large cap61st | 3.55% | 1.58 | 3,285 | Jul 2022or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 3.11% | 1.38 | 6,752 | Jul 2022or earlier |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 2.89% | 1.28 | 7,695 | Jul 2022or earlier |
| Fortis HealthcareHealthcare Services | Mid cap156th | 2.51% | 1.12 | 14,514 | Jul 2022or earlier |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap176th | 2.17% | 0.96 | 4,168 | Jul 2022or earlier |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Mid cap164th | 1.89% | 0.84 | 1,632 | Jul 2022or earlier |
| Zydus LifesciencesPharmaceuticals & Biotechnology | Mid cap114th | 1.82% | 0.81 | 6,948 | Jul 2022or earlier |
| Mankind PharmaPharmaceuticals & Biotechnology | Mid cap119th | 1.75% | 0.78 | 3,107 | Sep 2023 |
Weight is per cent of the fund's net assets; value in ₹ crore. 1 line filed with no weight is listed without one.
Cash and receivables on 30 Sep 2026
| Net Receivables / (Payables) | 0.09% | 0.05 |
Weight is per cent of the fund's net assets; value in ₹ crore. 1 line filed with no weight is listed without one.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions. Largest holding in the glossary
- 12.33%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions. Top 5 holdings in the glossary
- 34.59%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions. Top 10 holdings in the glossary
- 53.19%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights. Effective number of holdings in the glossary
- 24.9Taken over 99.91% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought. Asset allocation in the glossary- Indian shares99.91%
- Cash and receivables0.09%
Per cent of the fund's net assets.
Large, mid and small cap
- Large cap33.33%
- Mid cap38.52%
- Small cap28.15%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets. Sector weight in the glossary1sector
- Healthcare99.91%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare138 companies | 99.91% | 99.90% | 99.67% | 99.79% | 99.92% | 99.88% | 99.90% | 99.85% | 99.91% | 99.88% | 99.86% | 99.86% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before. New positions in the glossary
- 160.62% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date. Sold out in the glossary
- 30.03% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth. Added to in the glossary
- 114
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth. Trimmed in the glossary
- 8
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price. Unchanged in the glossary
- 0
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month. Traded at least in the glossary
- 0.03%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it. Weight that moved in the glossary
- 3.81%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). What changed in the glossary | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. Change in weight in the glossary | ||||
|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Trimmed | 3.55% | 4.35% | −0.80 pts | −635 |
| Sun Pharmaceutical Industries | Added | 12.33% | 12.92% | −0.59 pts | +465 |
| Dr. Reddy's Laboratories | Added | 4.73% | 4.34% | +0.39 pts | +263 |
| Fortis Healthcare | Added | 2.51% | 2.89% | −0.38 pts | +225 |
| Laurus Labs | Added | 4.84% | 4.47% | +0.37 pts | +325 |
| Apollo Hospitals Enterprise | Added | 5.21% | 5.53% | −0.32 pts | +44 |
| Rubicon Research | Added | 0.67% | 0.35% | +0.32 pts | +985 |
| Max Healthcare Institute | Added | 4.32% | 4.61% | −0.29 pts | +319 |
| Divi's Laboratories | Added | 7.42% | 7.21% | +0.21 pts | +55 |
| Anthem Biosciences | Trimmed | 0.58% | 0.77% | −0.19 pts | −869 |
| CORONA Remedies | Added | 0.25% | 0.08% | +0.17 pts | +360 |
| Wockhardt | Added | 1.10% | 0.95% | +0.15 pts | +36 |
| Biocon | Trimmed | 1.63% | 1.77% | −0.14 pts | −39 |
| Emcure Pharmaceuticals | Added | 0.51% | 0.39% | +0.12 pts | +227 |
| Ind-Swift Laboratories | New | 0.12% | 0.00% | +0.12 pts | +1,357 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | 13.10%Added | 14.08%Added | 13.40%Added | 13.16%Added | 13.46%Cut | 14.43%Added | 13.91%Cut | 13.20%Cut | 12.87%Cut | 13.32%Added | 12.92%Added | 12.33%Added |
 Divi's Laboratories | 6.31%Added | 6.01%Added | 6.01%Added | 6.03%Added | 5.99%Cut | 5.76%Cut | 5.90%Cut | 5.76%Cut | 5.36%Cut | 6.37%Added | 7.21%Added | 7.42%Added |
 Apollo Hospitals Enterprise | 5.67%Added | 5.37%Added | 5.31%Added | 5.55%Added | 5.86%Cut | 5.77%Cut | 5.55%Cut | 5.67%Cut | 5.68%Cut | 5.67%Added | 5.53%Added | 5.21%Added |
 Laurus Labs | 2.72%Added | 2.92%Added | 3.18%Added | 2.93%Added | 3.06%Cut | 2.93%Cut | 3.04%Cut | 3.59%Cut | 3.72%Cut | 4.32%Added | 4.47%Added | 4.84%Added |
 Cipla | 6.14%Added | 6.21%Added | 6.30%Added | 5.85%Added | 5.59%Cut | 5.26%Cut | 5.28%Cut | 5.37%Cut | 5.30%Cut | 5.17%Added | 4.90%Added | 4.79%Added |
 Dr. Reddy's Laboratories | 5.36%Added | 5.58%Added | 5.71%Added | 5.80%Added | 5.75%Cut | 5.82%Cut | 5.74%Cut | 5.39%Cut | 5.29%Cut | 4.34%Added | 4.34%Added | 4.73%Added |
 Max Healthcare Institute | 6.23%Added | 6.26%Added | 5.70%Added | 5.53%Added | 5.92%Cut | 5.41%Cut | 5.23%Cut | 4.84%Cut | 5.35%Cut | 5.04%Added | 4.61%Added | 4.32%Added |
 Torrent Pharmaceuticals | 2.74%Added | 2.84%Added | 2.97%Added | 3.25%Added | 3.34%Cut | 3.26%Cut | 3.03%Cut | 3.03%Cut | 3.00%Cut | 4.52%Added | 4.35%Added | 3.55%Cut |
 Lupin | 3.49%Added | 3.67%Added | 3.77%Added | 4.07%Added | 4.09%Cut | 4.26%Cut | 3.97%Cut | 3.74%Cut | 3.75%Cut | 3.63%Added | 3.23%Added | 3.11%Added |
 Aurobindo Pharma | 2.33%Added | 2.48%Added | 2.43%Added | 2.64%Added | 2.50%Cut | 2.76%Cut | 2.76%Cut | 2.71%Cut | 2.81%Cut | 2.73%Added | 2.88%Added | 2.89%Added |
 Fortis Healthcare | 3.91%Added | 3.49%Added | 3.40%Added | 3.47%Added | 3.60%Cut | 3.15%Cut | 3.43%Cut | 3.29%Cut | 3.19%Cut | 3.05%Added | 2.89%Added | 2.51%Added |
 Glenmark Pharmaceuticals | 2.08%Added | 2.12%Added | 2.25%Added | 2.36%Added | 2.35%Cut | 2.43%Cut | 2.56%Cut | 2.31%Cut | 2.11%Cut | 2.07%Added | 2.28%Added | 2.17%Added |
 Alkem Laboratories | 2.27%Added | 2.33%Added | 2.38%Added | 2.60%Added | 2.42%Cut | 2.36%Cut | 2.25%Cut | 2.19%Cut | 2.09%Cut | 2.09%Added | 1.92%Added | 1.89%Added |
 Zydus Lifesciences | 1.80%Added | 1.73%Added | 1.70%Added | 1.74%Added | 1.70%Cut | 1.67%Cut | 1.60%Cut | 1.84%Cut | 1.79%Cut | 1.76%Added | 1.79%Added | 1.82%Added |
 Mankind Pharma | 1.95%Added | 1.83%Added | 1.81%Added | 1.85%Added | 1.84%Cut | 1.70%Cut | 1.78%Cut | 1.80%Cut | 1.82%Cut | 1.71%Added | 1.64%Added | 1.75%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it. Portfolio turnover in the glossary
Highest 115.0% in Apr 2023
Risk ratios
NAV to 27 Oct 2026
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves. Standard deviation in the glossary16.51%
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure. Downside deviation in the glossary9.03%
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV. Sharpe ratio in the glossary0.89
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down. Sortino ratio in the glossary1.48
Against BSE Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less. Beta in the glossary1.00
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100. R-squared in the glossary100.0
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together). Correlation in the glossary1.00
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months. Upside capture in the glossary100.7%
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months. Downside capture in the glossary99.8%
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. Largest fall in the glossary | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. Back at the high in the glossary |
|---|---|---|---|---|
| 1 year | −9.97% | 23 Sep 2026 | 23 Oct 2026 | Not yet |
| 3 years and since Aug 2022 | −16.15% | 2 Jan 2025 | 28 Feb 2025 | 29 Jul 2025 |
Risk level by month
| Months | Fund | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. Benchmark's risk level in the glossary |
|---|---|---|
| Jul 2023 to Aug 202638 months | Very High | Very HighBSE Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Motilal Oswal BSE Healthcare ETF fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. Return in the manager's time in the glossary | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. Benchmark over the same days in the glossary | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. Difference from the benchmark in the glossary | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. Portfolio changed after the handover in the glossary | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. Portfolio changed before the handover in the glossary | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. Assets the manager runs in the glossary | ||
|---|---|---|---|---|---|---|---|---|
| Swapnil Mayekar | – | – | – | – | – | 28 | ₹31,909 Cr₹12,778 Cr alone | |
| Rakesh ShettyFor Debt Component | Nov 2022 | +20.38%a year | – | – | 4.6% | 5.8% | 39 | ₹85,523 Cr₹4,624 Cr alone |
Returns are the regular plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | |||||
|---|---|---|---|---|---|
| Motilal Oswal Nasdaq 100 Fund of FundSwapnil Mayekar | Nov 2018 | +24.35%a year | – | – | ₹8,032 Cr |
| Motilal Oswal Nifty India Defence Index FundSwapnil Mayekar | Jul 2024 | +1.70%a year | +2.96% | −1.26 pts | ₹5,434 Cr |
| Motilal Oswal Large and Midcap FundRakesh Shetty | Nov 2022 | +19.45%a year | +12.06% | +7.39 pts | ₹19,832 Cr |
| Motilal Oswal Flexi cap FundRakesh Shetty | Nov 2022 | +14.88%a year | +9.83% | +5.05 pts | ₹13,446 Cr |
| Motilal Oswal Small Cap FundRakesh Shetty | Dec 2023 | +16.73%a year | +6.67% | +10.06 pts | ₹8,298 Cr |
| Motilal Oswal Nasdaq 100 Fund of FundRakesh Shetty | Nov 2022 | +31.97%a year | – | – | ₹8,032 Cr |
| Motilal Oswal Nifty India Defence Index FundRakesh Shetty | Jul 2024 | +1.70%a year | +2.96% | −1.26 pts | ₹5,434 Cr |
| Motilal Oswal ELSS Tax Saver FundRakesh Shetty | Nov 2022 | +17.69%a year | +9.83% | +7.86 pts | ₹4,890 Cr |
| Motilal Oswal Multi Cap FundRakesh Shetty | Jun 2024 | +14.53%a year | −0.04% | +14.58 pts | ₹4,601 Cr |
| Motilal Oswal S&P 500 Index FundRakesh Shetty | Nov 2022 | +22.66%a year | – | – | ₹4,584 Cr |
The ten largest by assets, by manager. Returns are the regular plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. Portfolio overlap in the glossary | Shared holdings. The number of securities both funds hold, cash and futures left out. Shared holdings in the glossary | |
|---|---|---|
| DSP Nifty Healthcare ETFDSP Mutual Fund | 70.20% | 20 |
| ICICI Prudential Nifty Healthcare ETFICICI Prudential Mutual Fund | 70.20% | 20 |
| Nippon India Nifty Pharma ETFNippon India Mutual Fund | 61.15% | 20 |
| HDFC Nifty Growth Sectors 15 ETFHDFC Mutual Fund | 20.26% | 4 |
| Nippon India Nifty India Manufacturing ETFNippon India Mutual Fund | 18.47% | 11 |
| Motilal Oswal Nifty India Manufacturing ETFMotilal Oswal Mutual Fund | 18.44% | 11 |
| HDFC Nifty100 Low Volatility 30 ETFHDFC Mutual Fund | 17.60% | 5 |
| Kotak Nifty 100 Low Volatility 30 ETFKotak Mahindra Mutual Fund | 17.60% | 5 |
| ICICI Prudential Nifty 100 Low Volatility 30 ETFICICI Prudential Mutual Fund | 17.59% | 5 |
| Nippon India ETF Nifty 50 Shariah BeESNippon India Mutual Fund | 17.42% | 4 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Asset allocation
- Constituents of S&P BSE Healthcare Total Return Index 95-100%
Type of scheme
ETF
- Benchmark
- S&P BSE Healthcare Total Return Index
- Risk level at launch
- Very high
- New fund offer
- 14 Jul 2022 to 22 Jul 2022
- Units first allotted
- 29 Jul 2022
- Open for sale again
- 4 Aug 2022
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹500
Plans and codes
| Plan | AMFI code | ISIN | First NAV |
|---|---|---|---|
| Regular Growth | 150445 | INF247L01BB1 | 4 Aug 2022 |
This fund
- Scheme information documentThe fund's objective, terms, costs and risks in full
Factsheet
- Factsheet september 2026 passiveMotilal Oswal Mutual Fund, Sep 2026
Statement of additional information
- SAI Motilal Oswal Mutual FundMotilal Oswal Mutual Fund, Oct 2026
Annual report
- Motilal mf index fund ar 2025-26Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf equity fund ar 2025-26Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf debt fund ar 2025-26Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf etf fund ar 2025-26Motilal Oswal Mutual Fund, Mar 2026
Riskometer disclosure
- Riskometer Output July 2026 Portfolio Motilal Oswal Mutual FundMotilal Oswal Mutual Fund, Jul 2026
Portfolio overlap disclosure
- Portfolio overlap data as on september 30,2026Motilal Oswal Mutual Fund, Sep 2026